A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)

Clinical trial NCT07086651 · COMPLETED

Trial details

NCT number: NCT07086651
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Castration Sensitive Prostate Cancer (mCSPC)Cancer of the Prostate Prostate Neoplasms Prostate Cancer

Start date: 2025-07-21
Primary completion: 2025-10-31
Enrollment: 1300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.